First Angiotensin Receptor Blocker Prescription Filled After Hospital Discharge.
First Angiotensin Receptor Blocker Prescription Filled After Hospital Discharge.
Geoffrey M. Anderson (155717) +6 more
core +1 more source
New standards in hypertension and cardiovascular risk management: focus on telmisartan
Domenico Galzerano1, Cristina Capogrosso4, Sara Di Michele2, Antonio Galzerano1, Paola Paparello1, Diana Lama3, Carlo Gaudio21Department of Cardiology, San Gennaro Hospital, Naples, Italy; 2Department of Heart and Great Vessels, A.
Domenico Galzerano +3 more
doaj
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage. [PDF]
Zhang C +11 more
europepmc +1 more source
Jocelyn D Jones,1 Sylvia H Jackson,1 Charlie Colquitt21College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Jacksonville, FL, USA; 2College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tampa, FL ...
Jones JD, Jackson SH, Colquitt C
doaj
Construction Immune Related Feed-Forward Loop Network Reveals Angiotensin II Receptor Blocker as Potential Neuroprotective Drug for Ischemic Stroke. [PDF]
Bo C +9 more
europepmc +1 more source
Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker. [PDF]
Jun HR +7 more
europepmc +1 more source
Comparison between High-dose Telmisartan and Fixed dose Combination of Telmisartan and Hydrochlorothiazide in Patients with Hypertension [PDF]
We compared treatment with a high-dose angiotensin II receptor blocker(ARB)and combination of ARB with a thiazide diuretic in 17 patients with hypertension.
Murayama, Yoshiki +4 more
core
Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis. [PDF]
Lee HW, Suh JK, Jang E, Lee SM.
europepmc +1 more source
Correction: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. [PDF]
PLOS ONE Staff.
europepmc +1 more source
The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. [PDF]
Takagi H +11 more
europepmc +1 more source

